Pharming (PHAR) Asset Utilization Ratio (2021 - 2026)

Pharming (PHAR) has 6 years of Asset Utilization Ratio data on file, last reported at 0.77 in Q2 2026.

• Quarterly Asset Utilization Ratio rose 311.1% year-over-year to 0.77 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.77 (up 311.1% YoY) and the FY2025 annual result came in at 0.84, up 21.34% from the prior year.
• Asset Utilization Ratio grew to 0.77 in Q2 2026, from 0.41 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 128752.78 in Q2 2023 to a low of 0.0 in Q3 2022.
• A 5-year average of 27721.73 and a median of 0.48 in 2024 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio soared 209041426394.01% — and 2024, when it tumbled 100.0%.
• Tracing PHAR's Asset Utilization Ratio over 5 years: stood at 0.0 in 2022, then surged by 7739433791.11% to 122092.35 in 2023, then plunged by 100.0% to 0.45 in 2024, then increased by 29.45% to 0.58 in 2025, then surged by 31.76% to 0.77 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.77 (Q2 2026), 0.41 (Q1 2026), and 0.58 (Q4 2025), per Business Quant data.